Ortho Clinical Diagnostics Holdings plc (OCDX) Prices 76M Share IPO at $17/Sh

Go back to Ortho Clinical Diagnostics Holdings plc (OCDX) Prices 76M Share IPO at $17/Sh

Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering

January 27, 2021 8:27 PM EST

RARITAN, N.J., Jan. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share. The gross proceeds raised from this offering are expected to be $1,292 million. Ortho's ordinary shares are expected to begin trading on The Nasdaq Global Select Market on January 28, 2021, under the symbol "OCDX," and the offering is expected to close on February 1, 2021, subject to customary closing conditions.

... More